Document is current
Any future updates will be listed below
-
Authors
Roy, Alvaro
Tomé, Irene
Romero, Beatriz
Lorente-Leal, Víctor
Infantes-Lorenzo, José A.
Domínguez, Mercedes
Martín, Carlos
Aguiló, Nacho
Puentes, Eugenia
Rodríguez, Esteban
de Juan, Lucía
Risalde, María A.
Gortázar, Christian
Domínguez, Lucas
Bezos, Javier http://orcid.org/0000-0003-1913-0545
-
Funding
Funding for this research was provided by:
MINECO (IPT-2012-0327-090000, DI15-08110, IJCI-2015-24805)
- License Information
-
More Information
Article History
Received: 22 April 2019
Accepted: 25 September 2019
First Online: 15 October 2019
Ethics approval and consent to participate
: This study was carried out according to European legislation (Directive 2010/63/EU) and Spanish legislation (RD 53/2013), and was approved by the Ethics Committee (Complutense University of Madrid) and the Regional Agriculture Authority [Comunidad de Madrid (permit PROEX: 411/15)].
: EP, ER and AR are employees of CZ Vaccines, the owner of the Patent METHODS AND COMPOSITIONS FOR TUBERCULOSIS DIAGNOSIS (EP3330286) related to P22.
